NEW YORK (Reuters Health) – In patients with chronic total coronary occlusions, drug-eluting stents (DES) have better long-term outcomes than bare metal stents, according to a paper from…
NEW YORK (Reuters Health) – Consistent with their ability to block platelet aggregation, selective serotonin reuptake inhibitors (SSRIs) appear to increase the risk of serious upper gastrointestinal (GI)…
NEW YORK (Reuters Health) – A six-month course of triple antiplatelet therapy after drug-eluting stent implantation reduces the risk of revascularization for up to two years, according to…
NEW YORK (Reuters Health) – Thoracic endovascular aortic repair (TEVAR) improves aortic remodeling in patients with stable dissection of the descending aorta, but it remains unclear whether long-term…
NEW YORK (Reuters Health) – Androgen suppression therapy – and its attendant side effects — may not be necessary for patients with intermediate-risk prostate cancer treated with combination…
NEW YORK (Reuters Health) – Endoscopic resection of large colonic polyps is a safe and cost-effective alternative to surgery, according to a paper in the December issue of…
NEW YORK (Reuters Health) – Outpatient infusions of ketamine can significantly improve the severe pain of complex regional pain syndrome, a chronic problem after trauma, a small study…
NEW YORK (Reuters Health) – Nearly all patients have complications from chemoradiation for head and neck cancer, a study in the Archives of Otolaryngology: Head and Neck Surgery…
NEW YORK (Reuters Health) – Prophylactic, catheter-based normothermia reduces fever burden in neurointensive care unit patients with severe cerebrovascular disease, according to a report in the December Stroke.…
NEW YORK (Reuters Health) – Patients with angina and multivessel coronary artery disease face poor long-term outcomes with medical management, according to a report in the December issue…